Table 2.
Clinical signs of toxicity in mice and extrapolation in humans.
Clinical Signs of Toxicity in Mice. | Anatomical or Physiological Support | Possible Outcome in Humans |
---|---|---|
Loss of motor activity | Neuromuscular junction impairment (skeletal muscles) | Myasthenic syndrome analogous with the disease myasthenia gravis Flaccid paralysis caused by curare |
Respiratory depression/arrest | Neuromuscular junction impairment/block (diaphragm) | Respiratory impairment/arrest in myasthenia and myasthenic crisis |
Seizure | Central damage via nAChR inhibition | Seizure crisis (impaired GABA release or hereditary mutations) |
Leg extension | Spinal interneuron impairment Central impairment |
Pyramidal syndrome Babinski sign |
Reversibility if no death occurs or after prostigmine injection |
Removal of the post-synaptic neuromuscular block | Fluctuation in the degree of myasthenic syndrome or temporary removal of the block with prostigmine Removal of the curare action |
Exophthalmos | Increased intraocular pressure | Action of suxamethonium Action of lupin |
Hypersalivation, vomiting, diarrhea, bradycardia, bronchoconstriction, miosis | Inhibition of neuronal communication at ganglia synapses | Autonomous agents acting on the sympathetic nervous system (side effects). Nicotinic syndrome |
Tachycardia, blood hypertension, mydriasis | Inhibition of neuronal communication at ganglia synapses | Autonomous agents acting on the parasympathetic nervous system (side effects). Muscarinic syndrome |